Assessment of Intellectual, Psychological and Behavioural Developments Between 6 and 9 Years of the Children Born to Hyperthyroid Mothers During Their Pregnancy (EDIEMHYPER)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01779817 |
Recruitment Status : Unknown
Verified June 2018 by University Hospital, Angers.
Recruitment status was: Recruiting
First Posted : January 30, 2013
Last Update Posted : June 15, 2018
|
Tracking Information | ||||
---|---|---|---|---|
First Submitted Date ICMJE | January 28, 2013 | |||
First Posted Date ICMJE | January 30, 2013 | |||
Last Update Posted Date | June 15, 2018 | |||
Study Start Date ICMJE | February 2013 | |||
Estimated Primary Completion Date | January 2019 (Final data collection date for primary outcome measure) | |||
Current Primary Outcome Measures ICMJE |
Scores of global development Quotient (WISC-R) [ Time Frame: within the first 30 days after inclusion of the patient ] | |||
Original Primary Outcome Measures ICMJE | Same as current | |||
Change History | ||||
Current Secondary Outcome Measures ICMJE |
|
|||
Original Secondary Outcome Measures ICMJE | Same as current | |||
Current Other Pre-specified Outcome Measures | Not Provided | |||
Original Other Pre-specified Outcome Measures | Not Provided | |||
Descriptive Information | ||||
Brief Title ICMJE | Assessment of Intellectual, Psychological and Behavioural Developments Between 6 and 9 Years of the Children Born to Hyperthyroid Mothers During Their Pregnancy | |||
Official Title ICMJE | Assessment of Intellectual, Psychological and Behavioural Developments Between 6 and 9 Years of the Children Born to Hyperthyroid Mothers During Pregnancy | |||
Brief Summary |
|
|||
Detailed Description |
Multicentric, comparative study of a troop of child born to hyperthyroïd mothers during pregnancy (children exposed to the maternal hyperthyroïd) and children born to euthyroïd mothers during pregnancy (nonexposed children with the maternal hyperthyroïd).
|
|||
Study Type ICMJE | Interventional | |||
Study Phase ICMJE | Phase 4 | |||
Study Design ICMJE | Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Other |
|||
Condition ICMJE | Hyperthyroid | |||
Intervention ICMJE | Behavioral: Assessment of intellectual development, capacities of attention, learning process and degree of hyperactivity of the children between 6 and 9 years. | |||
Study Arms ICMJE |
|
|||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
||||
Recruitment Information | ||||
Recruitment Status ICMJE | Unknown status | |||
Estimated Enrollment ICMJE |
252 | |||
Original Estimated Enrollment ICMJE | Same as current | |||
Estimated Study Completion Date ICMJE | January 2019 | |||
Estimated Primary Completion Date | January 2019 (Final data collection date for primary outcome measure) | |||
Eligibility Criteria ICMJE |
A-For the child born to hyperthyroid mother during pregnancy : Discovered of a thyroid dysfonction at the time of the entry in the study B-For hyperthyroid mother during pregnancy: Discovered of a thyroid dysfonction at the time of the entry in the study C-For the child born to euthyroid mother during pregnancy: Discovered of a thyroid dysfonction at the time of the entry in the study D-For euthyroid mother during pregnancy: oDiscovered of a thyroid dysfonction at the time of the entry in the study oCarrying anti-TPO antibody at the time of the entry in the study |
|||
Sex/Gender ICMJE |
|
|||
Ages ICMJE | 6 Years to 9 Years (Child) | |||
Accepts Healthy Volunteers ICMJE | Yes | |||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries ICMJE | France | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number ICMJE | NCT01779817 | |||
Other Study ID Numbers ICMJE | PHRC 2011-01 | |||
Has Data Monitoring Committee | No | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement ICMJE | Not Provided | |||
Responsible Party | University Hospital, Angers | |||
Study Sponsor ICMJE | University Hospital, Angers | |||
Collaborators ICMJE | Not Provided | |||
Investigators ICMJE |
|
|||
PRS Account | University Hospital, Angers | |||
Verification Date | June 2018 | |||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |